A01K 2217/203
Animal model comprising inducible/conditional expression system
Official title: Animal model comprising inducible/conditional expression system, e.g. hormones, tet
A01K2217/203 (Animal model comprising inducible/conditional expression system) appears on 120 US grants and 247 published applications in this corpus.
Search patents in A01K- Granted patents
- 120
- Published applications
- 247
- Assignees
- 141
- Inventors
- 503
- Latest grant
- 24 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 5 |
| 2009 | 2 | 4 |
| 2010 | 0 | 14 |
| 2011 | 4 | 13 |
| 2012 | 3 | 11 |
| 2013 | 4 | 16 |
| 2014 | 7 | 7 |
| 2015 | 10 | 19 |
| 2016 | 9 | 10 |
| 2017 | 10 | 18 |
| 2018 | 12 | 15 |
| 2019 | 8 | 13 |
| 2020 | 7 | 15 |
| 2021 | 6 | 14 |
| 2022 | 10 | 22 |
| 2023 | 10 | 10 |
| 2024 | 4 | 13 |
| 2025 | 8 | 19 |
| 2026 | 5 | 6 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Mutant myocilin disease model and uses thereof24 Mar 2026US 12,582,104 B2Regeneron Pharmaceuticals, Inc.
- Application of TPK as a target in Alzheimer's disease17 Mar 2026US 12,575,549 B2Shanghai Raising Pharmaceutical Co., Ltd.
- Compositions for treatment of wet age-related macular degeneration24 Feb 2026US 12,558,434 B2Regenx Bio Inc
- Auxin-inducible degron system kit and use thereof17 Feb 2026US 12,553,055 B2Inter-University Research Institute Corporation Research Organization of Information and Systems
- Nonhuman animal and use for same13 Jan 2026US 12,522,836 B2Inter-University Reseach Institute Corporation Research Organization of Informaton and Systems
- Transgenic model of human cardiomyopathy8 Oct 2026US 2026/0305586 A1Stichting Genetische Hartspierziekte PLN
- Methods of eliciting immuno-tolerance using soluble immune checkpoint proteins27 Aug 2026US 2026/0250716 A1Duke University
- A method for detecting protein targets of an enzyme using a biotin ligase20 Aug 2026US 2026/0243776 A1Leibniz-Institut Fur Alternsforschung—Fritz-Lipmann-Institut E.V. (Fli)
- Composition for inducing proliferation or accumulation of regulatory t cells30 Apr 2026US 2026/0115235 A1The University of Tokyo
- Intracellular cx3cl1 domain peptides and uses thereof26 Feb 2026US 2026/0055152 A1
Most cited
By later US patents
- Composition for inducing proliferation or accumulation of regulatory T cells98US 9,808,519 B2The University of Tokyo · 2017
- Transgenic mouse for targeted recombination mediated by modified Cre-ER97US 7,112,715 B2Gie-Cerbm, Centre Europeen de Recherche en Biologie et en Medecine (GIE) · 2006
- Composition for inducing proliferation or accumulation of regulatory T cells85US 9,662,381 B2The University of Tokyo · 2017
- Composition for inducing proliferation or accumulation of regulatory T cells53US 9,433,652 B2The University of Tokyo · 2016
- Composition for inducing proliferation or accumulation of regulatory T cells51US 9,421,230 B2The University of Tokyo · 2016